Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01734668 · ClinicalTrials.gov registry record
Sofia RSV FIA Field Study
A clinical trial, sponsored by Quidel Corporation.
- Completed
- Registry status
- 2,468
- Enrollment target
NCT01734668: Completed study, sponsored by Quidel Corporation.
NCT01734668 is a clinical trial that has completed, run by Quidel Corporation. The registered enrollment target is 2,468 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01734668 has completed, sponsored by Quidel Corporation.
- COMPLETED
- Registry status
- 2,468 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate the clinical performance of the Sofia RSV FIA with specimens from symptomatic pediatric subjects who are less than nineteen (19) years of age.
Primary Outcome
Clinical performance will be based on comparison of the Sofia RSV FIA results to cell culture.
Interventions
- DEVICE In Vitro Diagnostic device to aid in diagnosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,468 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-01 |
What the finished NCT01734668 record still lists
NCT01734668 is an observational study that tracks outcomes without assigning an intervention. Its 2,468 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which In Vitro Diagnostic device to aid in diagnosis is the first listed.
NCT01734668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01734668 about?
NCT01734668 is a clinical study titled "Sofia RSV FIA Field Study". The objective of this study is to demonstrate the clinical performance of the Sofia RSV FIA with specimens from symptomatic pediatric subjects who are less than nineteen (19) years of age.
What is the current status of trial NCT01734668?
This trial is currently completed. The enrollment target is 2,468 participants. The study started on 2012-03. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01734668?
The interventions under investigation include: In Vitro Diagnostic device to aid in diagnosis (DEVICE).
Who is sponsoring clinical trial NCT01734668?
This trial is sponsored by Quidel Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06898593 · 2,448 participants · NA
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia